Jing Watnick

Affiliations

Vigeo Therapeutics, Cambridge, MA, USA. Jing.Watnick@vigeotx.com.

ORCID: http://orcid.org/0000-0003-0475-3299

Publications (2)

First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.

Communications medicine

Avec: Devalingam Mahalingam , Wael Harb , Amita Patnaik , Andrea Bullock , Randolph S Watnick , Melanie Y Vincent , Jian Jenny Chen , Suming Wang , Harold Pestana , Judy Chao , James Mahoney , Michael Cieslewicz , Jing Watnick

Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors.

Communications medicine

Avec: Jian Jenny Chen , Melanie Y Vincent , Dale Shepard , David Peereboom , Devalingam Mahalingam , James Battiste , Manish R Patel , Dejan Juric , Patrick Y Wen , Andrea Bullock , Jennifer Eva Selfridge , Shubham Pant , Joyce Liu , Wendy Li , Susanne Fyfe , Suming Wang , Victor Zota , James Mahoney , Randolph S Watnick , Michael Cieslewicz , Jing Watnick

Réseau de co-auteurs

Devalingam Mahalingam 2 collaborations

Andrea Bullock 2 collaborations

Randolph S Watnick 2 collaborations

Melanie Y Vincent 2 collaborations

Jian Jenny Chen 2 collaborations

Suming Wang 2 collaborations

James Mahoney 2 collaborations

Michael Cieslewicz 2 collaborations

Wael Harb 1 collaboration

Amita Patnaik 1 collaboration

Harold Pestana 1 collaboration

Judy Chao 1 collaboration

Dale Shepard 1 collaboration

David Peereboom 1 collaboration

James Battiste 1 collaboration

Manish R Patel 1 collaboration

Dejan Juric 1 collaboration

Patrick Y Wen 1 collaboration

Jennifer Eva Selfridge 1 collaboration

Shubham Pant 1 collaboration

Joyce Liu 1 collaboration

Wendy Li 1 collaboration

Susanne Fyfe 1 collaboration

Victor Zota 1 collaboration